📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points. (2011)

First Author: Wason JM

Attributed to: Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2010.12.007

PubMed Identifier: 21239164

Publication URI: http://europepmc.org/abstract/MED/21239164

Type: Journal Article/Review

Volume: 47

Parent Publication: European journal of cancer (Oxford, England : 1990)

Issue: 7

ISSN: 0959-8049